BrainsWay reported third-quarter 2026 revenue of $18.1 million, up 34% from a year earlier. The company shipped 130 Deep TMS systems during the quarter, up 44% year over year, bringing its reported installed base to approximately 2,080 systems. Operating income more than doubled to $2.6 million.
The company also reported follow-on minority investments of $3 million in Radial Health and $800,000 in Heading Health. After the quarter ended, BrainsWay entered into a collaboration with Inland Psychiatric Medical Group, a Southern California network with more than 30 locations. The agreement includes an order for multiple Deep TMS systems for planned installation at Inland clinics.
BrainsWay said it expects full-year revenue, operating margin, and adjusted EBITDA to come in at the upper end of its previous guidance ranges, with the potential to modestly exceed them.
